Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life. Part of the disease's danger is the ability of the bacteria to evade the body's immune system, but scientists are now figuring out how the pathogen hides in plain sight. Their findings, which could help defeat these bacteria and others like it, appear in the Journal of the American Chemical Society.
Linda Columbus and colleagues explain that the bacteria Neisseria meningitidis, one cause of meningitis, and its cousin Neisseria gonorrhoeae, which is responsible for gonorrhea, have key-like proteins that allow them to enter human cells and do their damage. Gonorrhea can be cured, though one type of the responsible bacteria has reached "superbug" status, becoming resistant to known drugs. If meningitis is not treated immediately with antibiotics, it can cause severe disability and death. In a search for new ways to treat these diseases, scientists are looking more closely at how the bacteria sneak around in the body undetected. When someone gets an infection, specific proteins - called antigens - that stud the pathogen's outer layer usually raise an alarm, and the body's immune system goes on the attack. But these two kinds of Neisseria bacteria can elude the body's look-out cells, and Columbus' team wanted to know how.
They combined two approaches to figure out the architecture of one of the bacteria's outer proteins that help it gain entry into human cells. They found that the protein's outer loops that jostle against each other, causing their structure to constantly change. This shape-shifting makes for a kind of camouflage that hides them from the body's sentinels, at the same time preserving its ability to bind to and enter a person's cells. This deeper understanding could help lead to new treatments for bacterial diseases, the scientists state.
The authors acknowledge funding from the National Science Foundation, Cottrell Scholar Award, the University of Virginia nanoSTAR and the National Institutes of Health.
Source: American Chemical Society
Weekly Rounds: Four Years of COVID-19, AORN 2024 Conference Coverage, and More
March 18th 2024Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
Could Empathy Help Overcome Vaccine Hesitancy?
March 14th 2024Research findings reveal that correcting misinformation about vaccination can remarkably transform individuals' attitudes toward it. This highlights the crucial role of accurate information in making informed decisions about vaccination.
Empowering Safety: A Massachusetts General Hospital Team Is Pushing for Smoke-Free ORs
March 13th 2024At the AORN’s International Surgical Conference & Expo 2024, a team from Massachusetts General Hospital (MGH) showcased their transformative project, "Becoming Smoke-Free in the OR." This initiative underscored the critical need for smoke evacuation in surgical settings.
Hand Hygiene Practices in the Operating Room: A Collaborative Endeavor
March 13th 2024As explained on a poster at AORN 2024, perioperative nurses and infection preventionists unite in a proactive campaign to elevate hand hygiene within the operating room, resulting in improved adherence, decreased infections, and fortified patient outcomes.